Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Mallinckrodt
Colorcon
Express Scripts
McKesson

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

Litigation Details for TEVA PHARMACEUTICAL INDUSTRIES LTD. v. LUPIN LIMITED (D.N.J. 2007)

See Plans and Pricing

« Back to Dashboard

TEVA PHARMACEUTICAL INDUSTRIES LTD. v. LUPIN LIMITED (D.N.J. 2007)

Docket   Start Trial Date Filed 2007-06-21
Court District Court, D. New Jersey Date Terminated 2007-10-30
Cause 28:2201 Declaratory Judgment Assigned To Garrett E. Brown Jr.
Jury Demand None Referred To Magistrate Judge John J. Hughe
Parties LUPIN LIMITED; LUPIN PHARMACEUTICALS, INC.; TEVA PHARMACEUTICALS INDUSTRIES, LTD.; TEVA PHARMACEUTICALS USA, INC.
Patents 4,503,067
Attorneys ARNOLD B. CALMANN; JAKOB BENJAMIN HALPERN; JEFFREY S. SOOS; MICHAEL E. PATUNAS
Link to Docket External link to docket
Small Molecule Drugs cited in TEVA PHARMACEUTICAL INDUSTRIES LTD. v. LUPIN LIMITED
The small molecule drugs covered by the patent cited in this case are   Start Trial and   Start Trial .

Details for TEVA PHARMACEUTICAL INDUSTRIES LTD. v. LUPIN LIMITED (D.N.J. 2007)

Date Filed Document No. Description Snippet Link To Document
2007-06-21 1 Complaint claimed in U.S. Patent No. 4,503,067 (“the ‘067 Patent”), which is owned by GSK. The ‘067 Patent is listed …IL); Shwmn wizel, U‘S' PATENT DOC“MEN"S Pf=lah quva (EL) 4,503,067_ A ' 3,/1985 Wiedemann…099). Synfhesis of Carvcclilol U.S. Pat. No. 4,503,067, which is incorporated herein by reference, discloses…099), Syrrthesis of Cztrvediloi U.S. Pal. No. 4.503.067. which is incorporated herein by reference discloses…099). Syn§hesis of Carvedilol U.S. Par. No. 4,503,067, which is incorporated herein by reference discioses External link to document
2007-07-31 9 Answer to Complaint in U.S. Patent No. 4,503,067 (“tlie ‘067 Patent”), Which is owned by GSK. 'l`he ‘067 Patent is listed…997 patent, the ’ 184 patent, the ’942 patent, and the "008 patent, collectively “the patents in …in United States Patent Nos. 6,699,997 (“the ‘997 Patent”), 6,7]0,184 (“the ‘184 Patent”), 7,056,942 (“…(“the ‘942 Patent”), and 7,126,008 (“the ‘008 Patent”; collectively, “the patents in suit”) relating to…Paragrap_h 5: This is an action for patent infringement arising under the Patent Lavvs of the United States, External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
McKesson
Mallinckrodt
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.